{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:43:51Z","timestamp":1792802631543,"version":"4.5.0"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijbiomac.2025.142141","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T12:09:19Z","timestamp":1741954159000},"page":"142141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P3","title":["Going beyond ATP binding site as a novel inhibitor design strategy for tau protein kinases in the treatment of Alzheimer's disease: A review"],"prefix":"10.1016","volume":"307","author":[{"given":"Marwa A.","family":"Zaater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"El Kerdawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa R.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar M.","family":"Abou-Seri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.142141_bb0005","unstructured":"WHO, WHO reveals leading causes of death and disability worldwide: 2000-2019, (n.d.). https:\/\/www.who.int\/news\/item\/09-12-2020-who-reveals-leading-causes-of-death-and-disability-worldwide-2000-2019 (accessed January 15, 2023)."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1582-4934.2008.00225.x","article-title":"Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention: Alzheimer review series","volume":"12","author":"Iqbal","year":"2008","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0015","doi-asserted-by":"crossref","unstructured":"W.C. Glenner, G. and Wong, Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein, Biochem. Biophys. Res. Commun. 122 (1984) 1131\u20131135. doi:https:\/\/doi.org\/10.1016\/0006-291X(84)91209-9.","DOI":"10.1016\/0006-291X(84)91209-9"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0020","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/neu.480250409","article-title":"Secreted forms of \u03b2-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons","volume":"25","author":"Mattson","year":"1994","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuint.2008.06.005","article-title":"Interactions between the amyloid and cholinergic mechanisms in Alzheimer\u2019s disease","volume":"53","author":"P\u00e1k\u00e1ski","year":"2008","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0030","unstructured":"KEGG PATHWAY: Alzheimer Disease - Homo sapiens, KEGG (2020). https:\/\/www.kegg.jp\/kegg-bin\/show_pathway?hsa05010 (accessed August 22, 2020)."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0035","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2008.11.007","article-title":"Linking A\u03b2 and tau in late-onset Alzheimer\u2019s disease: a dual pathway hypothesis","volume":"60","author":"Small","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0040","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1471-4159.2009.06511.x","article-title":"Tau oligomers and aggregation in Alzheimer\u2019s disease","volume":"112","author":"Meraz-R\u00edos","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0045","first-page":"55","article-title":"Neurobiology of Alzheimer\u2019s disease, Indian","volume":"51","author":"Mohandas","year":"2009","journal-title":"J. Psychiatry"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0050","first-page":"1","article-title":"Recent developments of protein kinase inhibitors as potential AD therapeutics","volume":"6","author":"Tell","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0055","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","article-title":"Tau protein kinases: Involvement in Alzheimer\u2019s disease","volume":"12","author":"Martin","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0060","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","article-title":"The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (review)","volume":"40","author":"Ardito","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0065","article-title":"Next generation kinase inhibitors: moving beyond the ATP binding\/catalytic sites","author":"Shapiro","year":"2020","journal-title":"Springer Nature"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0070","article-title":"The human Kinome and kinase inhibition","volume":"60","author":"Duong-Ly","year":"2013","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0075","first-page":"1409","article-title":"Small-molecule inhibitors binding to protein kinases","author":"Backes","year":"2008","journal-title":"Part I\u00a0: exceptions from the traditional pharmacophore"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0080","first-page":"440","article-title":"Defining the conserved internal architecture of a protein kinase","volume":"2010","author":"Kornev","year":"1804","journal-title":"Biochim. Biophys. Acta - Proteins Proteomics"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0085","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1021\/bi982672w","article-title":"Dissection of the nucleotide and metal\u2212phosphate binding sites in cAMP-dependent protein kinase\u2020","volume":"38","author":"Herberg","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0090","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1021\/cr000226k","article-title":"Dynamics of cAMP-dependent protein kinase","volume":"101","author":"Johnson","year":"2001","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202200328","article-title":"A perspective study on the RTK, PI3K, B-Raf, CDK and the multi-protein targeting in medicinal chemistry","volume":"19","author":"Mohamed","year":"2022","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0100","doi-asserted-by":"crossref","first-page":"E4623","DOI":"10.1073\/pnas.1418402111","article-title":"Dynamic architecture of a protein kinase","volume":"111","author":"McClendon","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0105","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.tibs.2018.12.002","article-title":"Disordered protein kinase regions in regulation of kinase domain cores","volume":"44","author":"G\u00f3gl","year":"2019","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.00242","article-title":"Clinically Precedented protein kinases: rationale for their use in neurodegenerative disease","volume":"12","author":"Benn","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.phrs.2015.10.021","article-title":"Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes","volume":"103","author":"Roskoski","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0120","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1021\/jm901443h","article-title":"Through the \u201cgatekeeper door\u201d: exploiting the active kinase conformation","volume":"53","author":"Zuccotto","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1039\/C2MD20180A","article-title":"Approaches to discover non-ATP site kinase inhibitors","volume":"4","author":"Gavrin","year":"2013","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0130","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature08675","article-title":"Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors","volume":"463","author":"Zhang","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0135","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/1535-7163.MCT-09-1012","article-title":"MK-2206, an allosteric akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo","volume":"9","author":"Hirai","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012913","article-title":"Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition","volume":"5","author":"Wu","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0145","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nature05998","article-title":"Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface","volume":"450","author":"Zhang","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0150","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1021\/cb100410m","article-title":"Discovery of a potential allosteric ligand binding site in CDK2","volume":"6","author":"Betzi","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0155","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/10409238.2013.875513","article-title":"Bivalent inhibitors of protein kinases","volume":"49","author":"Gower","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0160","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.2174\/138161212800672813","article-title":"New directions in targeting protein kinases: focusing upon true allosteric and bivalent inhibitors","volume":"18","author":"Lamba","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0165","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.neuint.2010.12.023","article-title":"Post-translational modifications of tau protein: implications for Alzheimer\u2019s disease","volume":"58","author":"Martin","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0170","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1016\/j.febslet.2006.02.067","article-title":"Tau phosphorylation and aggregation in Alzheimer\u2019s disease pathology","volume":"580","author":"Avila","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0175","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0197-4580(00)00191-3","article-title":"Alzheimer disease is multifactorial and heterogeneous","volume":"21","author":"Iqbal","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0180","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000067425","article-title":"Role of serine\/threonine protein phosphatase in Alzheimer\u2019s disease","volume":"11","author":"Tian","year":"2002","journal-title":"Neurosignals"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0185","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/YCO.0b013e328314b78b","article-title":"Neurofibrillary degeneration in Alzheimer\u2019s disease: from molecular mechanisms to identification of drug targets","volume":"21","author":"Pei","year":"2008","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0190","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1101\/gad.1152403","article-title":"Opportunities and challenges in the development of kinase inhibitor therapy for cancer","volume":"17","author":"Sawyers","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0195","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1158\/1078-0432.CCR-13-1610","article-title":"Molecular pathways: resistance to kinase inhibitors and implications for therapeutic strategies","volume":"20","author":"Lovly","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0200","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1517\/13543784.2011.546344","article-title":"Mechanisms of drug resistance in kinases","volume":"20","author":"Barouch-Bentov","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0205","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1158\/1078-0432.CCR-13-1610","article-title":"Molecular pathways: resistance to kinase inhibitors and implications for therapeutic strategies","volume":"20","author":"Lovly","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/cpbi.92","article-title":"How to illuminate the Druggable genome using Pharos","volume":"69","author":"Sheils","year":"2020","journal-title":"Curr. Protoc. Bioinforma."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0215","doi-asserted-by":"crossref","first-page":"D995","DOI":"10.1093\/nar\/gkw1072","article-title":"Pharos: collating protein information to shed light on the druggable genome","volume":"45","author":"Nguyen","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"2021","key":"10.1016\/j.ijbiomac.2025.142141_bb0220","doi-asserted-by":"crossref","first-page":"D1334","DOI":"10.1093\/nar\/gkaa993","article-title":"Mining the human proteome for disease biology","volume":"49","author":"Sheils","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0225","doi-asserted-by":"crossref","unstructured":"J. Pi\u00f1ero, J.M. Ram\u00edrez-Anguita, J. Sa\u00fcch-Pitarch, F. Ronzano, E. Centeno, F. Sanz, L.I. Furlong, The DisGeNET knowledge platform for disease genomics: 2019 update, Nucleic Acids Res. 48 (2020) D845\u2013D855. doi:https:\/\/doi.org\/10.1093\/NAR\/GKZ1021.","DOI":"10.1093\/nar\/gkz1021"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0230","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bav028","article-title":"DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes","volume":"2015","author":"Pi\u00f1ero","year":"2015","journal-title":"Database (Oxford)"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0235","doi-asserted-by":"crossref","first-page":"D833","DOI":"10.1093\/nar\/gkw943","article-title":"DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants","volume":"45","author":"Pi\u00f1ero","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0240","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1432-1033.1980.tb06059.x","article-title":"Glycogen synthase Kinase-3 from rabbit skeletal muscle","volume":"107","author":"Embi","year":"1980","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0245","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/bj2940625","article-title":"Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B","volume":"294","author":"Welsh","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0250","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1476-5381.2008.00085.x","article-title":"Glycogen synthase kinase 3: more than a namesake","volume":"156","author":"Rayasam","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0255","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2009.09.007","article-title":"Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3)","volume":"31","author":"Beurel","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0260","doi-asserted-by":"crossref","unstructured":"I. Rippin, H. Eldar-Finkelman, Mechanisms and Therapeutic Implications of GSK-3 in Treating Neurodegeneration, Cells 2021, Vol. 10, Page 262 10 (2021) 262. doi:https:\/\/doi.org\/10.3390\/CELLS10020262.","DOI":"10.3390\/cells10020262"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2011.00032","article-title":"GSK-3 inhibitors: preclinical and clinical focus on CNS","volume":"4","author":"Eldar-Finkelman","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0270","first-page":"720","article-title":"Isolation and chromosomal mapping of human glycogen synthase kinase-3 alpha and \u22123 beta encoding genes","volume":"41","author":"Shaw","year":"1998","journal-title":"Genome"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22169098","article-title":"Gsk-3\u03b2, fyn, and dyrk1a: master regulators in neurodegenerative pathways","volume":"22","author":"Demuro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0280","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0092-8674(01)00374-9","article-title":"Crystal structure of glycogen synthase kinase 3\u03b2: structural basis for phosphate-primed substrate specificity and autoinhibition","volume":"105","author":"Dajani","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0285","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1074\/jbc.M206236200","article-title":"Glycogen synthase kinase 3\u03b2 phosphorylates tau at both primed and unprimed sites","volume":"278","author":"Cho","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0290","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","article-title":"Tau phosphorylation: the therapeutic challenge for neurodegenerative disease","volume":"15","author":"Hanger","year":"2009","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0295","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer\u2019s disease","volume":"104","author":"Hooper","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0300","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.expneurol.2009.09.011","article-title":"GSK3: a possible link between beta amyloid peptide and tau protein","volume":"223","author":"Hern\u00e1ndez","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2021.792364","article-title":"Glycogen synthase Kinase-3 inhibitors: preclinical and clinical focus on CNS-A decade onward","volume":"14","author":"Arciniegas Ruiz","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087541","article-title":"GSK-3\u03b2 allosteric inhibition: a dead end or a new pharmacological frontier?","volume":"24","author":"Balboni","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0315","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1021\/acs.jmedchem.0c00931","article-title":"Glycogen synthase kinase 3\u03b2: a new gold rush in anti-Alzheimer\u2019s disease multitarget drug discovery?","volume":"64","author":"De Simone","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0320","doi-asserted-by":"crossref","first-page":"8461","DOI":"10.1021\/jm200996g","article-title":"Exploring the binding sites of glycogen synthase kinase 3. Identification and characterization of allosteric modulation cavities","volume":"54","author":"Palomo","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0325","unstructured":"D. Gordillo, I. Diaz, A. Martinez-Gil, G. del Pliego, A. Huerta, Padilla, J.M. Puerto, E. Aparicio, D. Navarro, M. Padilla, GSK-3 inhibitors isolated from marine organisms, 20070088080, 2004. https:\/\/patents.google.com\/patent\/US20070088080A1\/en."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2006.05.2076","article-title":"P4\u2013335: glycogen synthase kinase\u20133\u03b2 inhibitors from marine origin","volume":"2","author":"Alonso","year":"2006","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0335","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejmech.2012.12.014","article-title":"Evidence for a new binding mode to GSK-3: allosteric regulation by the marine compound palinurin","volume":"60","author":"Bidon-Chanal","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0340","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/prot.1159","article-title":"Classical molecular interaction potentials: improved setup procedure in molecular dynamics simulations of proteins","volume":"45","author":"Gelp\u00ed","year":"2001","journal-title":"Proteins Struct. Funct. Bioinforma."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0345","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1021\/jm011020u","article-title":"First non-ATP competitive glycogen synthase kinase 3 \u03b2 (GSK-3\u03b2) inhibitors: Thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer\u2019s disease","volume":"45","author":"Martinez","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0350","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/08958378.2020.1741739","article-title":"TDZD-8 alleviates delayed neurological sequelae following acute carbon monoxide poisoning involving tau protein phosphorylation","volume":"32","author":"Su","year":"2020","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0355","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1164\/rccm.201606-1275CI","article-title":"Carbon monoxide poisoning: pathogenesis, management, and future directions of therapy","volume":"195","author":"Rose","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0360","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75020-w","article-title":"Structural modeling of GSK3\u03b2 implicates the inactive (DFG-out) conformation as the target bound by TDZD analogs","volume":"10","author":"Balasubramaniam","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0365","doi-asserted-by":"crossref","first-page":"13383","DOI":"10.1016\/S0021-9258(18)42222-3","article-title":"Purification and characterization of a novel proline-directed protein kinase from bovine brain","volume":"267","author":"Lew","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0370","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1097-2765(01)00343-4","article-title":"Structure and regulation of the CDK5-p25nck5a complex","volume":"8","author":"Tarricone","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0375","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1074\/jbc.271.3.1538","article-title":"Interaction of cyclin-dependent kinase 5 (Cdk5) and neuronal Cdk5 activator in bovine brain","volume":"271","author":"Lee","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0380","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1471-4159.2005.03301.x","article-title":"Activation of latent cyclin-dependent kinase 5 (Cdk5)-p35 complexes by membrane dissociation","volume":"94","author":"Zhu","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0385","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1523\/JNEUROSCI.18-16-06370.1998","article-title":"Cyclin-Dependent Kinase 5-Deficient Mice Demonstrate Novel Developmental Arrest in Cerebral Cortex","volume":"18","author":"Gilmore","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0390","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1523\/JNEUROSCI.19-14-06017.1999","article-title":"Migration defects of cdk5 \u2212\/\u2212 neurons in the developing cerebellum is cell autonomous","volume":"19","author":"Ohshima","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0395","doi-asserted-by":"crossref","first-page":"11173","DOI":"10.1073\/pnas.93.20.11173","article-title":"Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death","volume":"93","author":"Ohshima","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0400","doi-asserted-by":"crossref","first-page":"41495","DOI":"10.1074\/jbc.M406670200","article-title":"Regulation of the fusion pore conductance during exocytosis by cyclin-dependent kinase 5","volume":"279","author":"Barclay","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0405","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1471-4159.2005.03233.x","article-title":"Impairment of hippocampal long-term depression and defective spatial learning and memory in p35 \u2212\/\u2212 mice","volume":"94","author":"Ohshima","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0410","doi-asserted-by":"crossref","first-page":"10633","DOI":"10.1523\/JNEUROSCI.23-33-10633.2003","article-title":"Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice","volume":"23","author":"Hallows","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0415","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1007\/s12035-016-9792-7","article-title":"A tale of the Good and bad: remodeling of the microtubule network in the brain by Cdk5","volume":"54","author":"Shah","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0420","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1523\/JNEUROSCI.5628-09.2010","article-title":"Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1\u2013DP1 complex","volume":"30","author":"Zhang","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0425","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.neuron.2008.10.015","article-title":"Deregulation of HDAC1 by p25\/Cdk5 in neurotoxicity","volume":"60","author":"Kim","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0430","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.108183","article-title":"Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death","author":"Chang","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0435","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1021\/acschemneuro.0c00096","article-title":"Physiological and pathological roles of Cdk5: potential directions for therapeutic targeting in neurodegenerative disease","volume":"11","author":"Allnutt","year":"2020","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0440","article-title":"Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0445","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/35012636","article-title":"Neurotoxicity induces cleavage of p35 to p25 by calpain","volume":"405","author":"Lee","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0450","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/45159","article-title":"Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration","volume":"402","author":"Patrick","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0455","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/j.1471-4159.2008.05500.x","article-title":"Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cycline-dependent kinase 5 complexes","volume":"106","author":"Asada","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-021-00774-y","article-title":"Three decades of Cdk5","volume":"28","author":"Pao","year":"2021","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0465","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.2174\/138161209788682253","article-title":"Peptide inhibitors targeting protein kinases","volume":"15","author":"Eldar-Finkelman","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0470","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1046\/j.1432-1033.2002.03133.x","article-title":"A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells","volume":"269","author":"Zheng","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0475","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1523\/JNEUROSCI.3593-12.2013","article-title":"Specific inhibition of p25\/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo","volume":"33","author":"Sundaram","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0480","doi-asserted-by":"crossref","first-page":"34202","DOI":"10.1074\/jbc.M110.134643","article-title":"A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation","volume":"285","author":"Zheng","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0485","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.emboj.7600441","article-title":"A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons","volume":"24","author":"Zheng","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0490","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1096\/fj.12-217497","article-title":"A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer\u2019s disease phenotypes in model mice","volume":"27","author":"Shukla","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0495","first-page":"3","article-title":"TFP5 peptide, derived from CDK5-activating cofactor p35, provides neuroprotection in early-stage of adult ischemic stroke","volume":"7","author":"Bin Ji","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0500","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3233\/JAD-160916","article-title":"TFP5, a peptide inhibitor of aberrant and hyperactive Cdk5\/p25, attenuates pathological phenotypes and restores synaptic function in CK-p25Tg mice","volume":"56","author":"Shukla","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0505","doi-asserted-by":"crossref","unstructured":"B. BK, Y.-L. Zheng, V. Shukla, N.D. Amin, P. Grant, H.C. Pant, TFP5, a peptide derived from p35, a Cdk5 neuronal activator, rescues cortical neurons from glucose toxicity, J. Alzheimers Dis. 39 (2014) 899\u2013909. doi:https:\/\/doi.org\/10.3233\/JAD-131784.","DOI":"10.3233\/JAD-131784"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0510","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.3892\/etm.2016.3658","article-title":"TFP5 prevents 1-methyl-4-phenyl pyridine ion-induced neurotoxicity in mouse cortical neurons","volume":"12","author":"Zhang","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0515","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0896-6273(03)00259-9","article-title":"Cdk5 is a key factor in tau aggregation and tangle formation in vivo","volume":"38","author":"Noble","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0520","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/nan.12084","article-title":"Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer\u2019s disease and down syndrome","volume":"40","author":"Mondrag\u00f3n-Rodr\u00edguez","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0525","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.chembiol.2015.03.009","article-title":"Tamoxifen inhibits CDK5 kinase activity by interacting with p35\/p25 and modulates the pattern of tau phosphorylation","volume":"22","author":"Corbel","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0530","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0014-5793(02)03487-7","article-title":"Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3\u03b2","volume":"530","author":"Liu","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0535","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/jnen\/60.12.1190","article-title":"Activation of the JNK\/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis","volume":"60","author":"Atzori","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0540","doi-asserted-by":"crossref","unstructured":"I. Ferrer, R. Blanco, M. Carmona, R. Ribera, E. Goutan, B. Puig, M.J. Rey, A. Cardozo, F. Vi\u00f1als, T. Ribalta, Phosphorylated Map Kinase (ERK1, ERK2) Expression is Associated with Early Tau Deposition in Neurones and Glial Cells, but not with Increased Nuclear DNA Vulnerability and Cell Death, in Alzheimer Disease, Pick's Disease, Progressive Supranuclear Palsy an, Brain Pathol. 11 (2001) 144\u2013158. doi:https:\/\/doi.org\/10.1111\/j.1750-3639.2001.tb00387.x.","DOI":"10.1111\/j.1750-3639.2001.tb00387.x"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0545","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1046\/j.1471-4159.1999.0722053.x","article-title":"p38 kinase is activated in the Alzheimer\u2019s disease brain","volume":"72","author":"Hensley","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0550","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1097\/00001756-199908020-00035","article-title":"Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation","volume":"10","author":"Perry","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0555","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0169-328X(00)00245-X","article-title":"JNK activation is associated with intracellular \u03b2-amyloid accumulation","volume":"85","author":"Shoji","year":"2000","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0560","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0169-328X(02)00488-6","article-title":"Up-regulation of mitogen-activated protein kinases ERK1\/2 and MEK1\/2 is associated with the progression of neurofibrillary degeneration in Alzheimer\u2019s disease","volume":"109","author":"Pei","year":"2002","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0565","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1111\/j.0953-816X.2004.03365.x","article-title":"Increased MAP kinase activity in Alzheimer\u2019s and down syndrome but not in schizophrenia human brain","volume":"19","author":"Swatton","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0570","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0092-8674(00)00116-1","article-title":"Signal transduction by the JNK group of MAP kinases","volume":"103","author":"Davis","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0575","first-page":"1","article-title":"C-Jun N-terminal kinase inhibitors as potential leads for new therapeutics for Alzheimer\u2019s diseases","volume":"21","author":"Rehfeldt","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0580","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1503\/jpn.140062","article-title":"Increased levels of cerebrospinal fluid JNK3 associated with amyloid pathology: links to cognitive decline","volume":"40","author":"Gourmaud","year":"2015","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0585","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1046\/j.1471-4159.1997.68041736.x","article-title":"Stress-activated protein kinase\/c-Jun N-terminal kinase phosphorylates \u03c4 protein","volume":"68","author":"Reynolds","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0590","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1046\/j.1471-4159.2000.0741587.x","article-title":"Phosphorylation sites on tau identified by Nanoelectrospray mass spectrometry","volume":"74","author":"Reynolds","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0595","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1471-4159.2004.02479.x","article-title":"Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK)","volume":"90","author":"Yoshida","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0600","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1073\/pnas.95.5.2586","article-title":"A splicing variant of a death domain protein that is regulated by a mitogen-activated kinase is a substrate for c-Jun N-terminal kinase in the human central nervous system","volume":"95","author":"Zhang","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0605","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101431","article-title":"A perspective on the development of c-Jun n-terminal kinase inhibitors as therapeutics for alzheimer\u2019s disease: investigating structure through docking studies","volume":"9","author":"Cho","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0610","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1523\/JNEUROSCI.22-11-04335.2002","article-title":"C-Jun N-terminal protein kinase (JNK) 2\/3 is specifically activated by stress, mediating c-Jun activation, in the presence of constitutive JNK1 activity in cerebellar neurons","volume":"22","author":"Coffey","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0615","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1046\/j.1471-4159.2001.00102.x","article-title":"Phosphorylation of thr 668 in the cytoplasmic domain of the Alzheimer\u2019s disease amyloid precursor protein by stress-activated protein kinase 1b (Jun N-terminal kinase-3)","volume":"76","author":"Standen","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0620","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.nbd.2008.12.014","article-title":"JNK regulates APP cleavage and degradation in a model of Alzheimer\u2019s disease","volume":"33","author":"Colombo","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0625","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1471-4159.2007.05072.x","article-title":"Oxidative stress activates a positive feedback between the \u03b3- and \u03b2-secretase cleavages of the \u03b2-amyloid precursor protein","volume":"104","author":"Tamagno","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0630","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1091\/mbc.e10-04-0347","article-title":"Identification of a nuclear export signal in the catalytic subunit of AMP-activated protein kinase","volume":"21","author":"Kazgan","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0635","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0640","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease","volume":"8","author":"Panwar","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0645","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0650","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.neuron.2012.06.024","article-title":"JNK3 perpetuates metabolic stress induced by A\u03b2 peptides","volume":"75","author":"Yoon","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0655","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1101\/gad.922801","article-title":"Requirement of the JIP1 scaffold protein for stress-induced JNK activation","volume":"15","author":"Whitmarsh","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0660","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1101\/gad.1216504","article-title":"An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue","volume":"18","author":"Jaeschke","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0665","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3233\/JAD-2011-091567","article-title":"JNK3 as a therapeutic target for neurodegenerative diseases","volume":"24","author":"Antoniou","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0670","author":"Bonny"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0675","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diabetes.50.1.77","article-title":"Cell-permeable peptide inhibitors of JNK: novel blockers of \u03b2-cell death","volume":"50","author":"Bonny","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0680","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3233\/JAD-160509","article-title":"Dual kinase inhibition affords extended in vitro neuroprotection in amyloid-\u03b2 toxicity","volume":"54","author":"Gourmaud","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0685","doi-asserted-by":"crossref","first-page":"43871","DOI":"10.1074\/jbc.M111.297515","article-title":"C-Jun N-terminal kinase regulates soluble A\u03b2 oligomers and cognitive impairment in AD mouse model","volume":"286","author":"Sclip","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0690","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3233\/JAD-2011-110320","article-title":"JNK plays a key role in tau hyperphosphorylation in Alzheimer\u2019s disease models","volume":"26","author":"Ploia","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0695","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3233\/JAD-171099","article-title":"Brimapitide reduced neuronal stress markers and cognitive deficits in 5XFAD transgenic mice","volume":"63","author":"Gourmaud","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0700","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/bj3590497","article-title":"Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A","volume":"359","author":"Himpel","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0705","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.cell.2005.03.034","article-title":"Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs","volume":"121","author":"Lochhead","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0710","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nbd.2005.03.020","article-title":"Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, down syndrome, pick disease, and related transgenic models","volume":"20","author":"Ferrer","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0715","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/hmg\/ddl437","article-title":"The DYRK1A gene, encoded in chromosome 21 down syndrome critical region, bridges between \u03b2-amyloid production and tau phosphorylation in Alzheimer disease","volume":"16","author":"Kimura","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0720","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/bj3550609","article-title":"The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2B\u025b at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase","volume":"355","author":"Woods","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0725","doi-asserted-by":"crossref","first-page":"39819","DOI":"10.1074\/jbc.M104091200","article-title":"Protein kinase Dyrk1 activates cAMP response element-binding protein during neuronal differentiation in hippocampal progenitor cells","volume":"276","author":"Yang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0730","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1471-4159.2007.05075.x","article-title":"Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between down syndrome and Alzheimer\u2019s disease","volume":"104","author":"Ryoo","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0735","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/bj20021535","article-title":"The specificities of protein kinase inhibitors: an update","volume":"371","author":"Bain","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0740","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2023.116098","article-title":"EGCG-like non-competitive inhibitor of DYRK1A rescues cognitive defect in a down syndrome model","volume":"265","author":"Delabar","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0745","series-title":"Dyrk1a Gene Dosage in Glutamatergic Neurons Has Key Effects in Cognitive Deficits Observed in Mouse Models of MRD7 and Down Syndrome","author":"Brault","year":"2021"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0750","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041404","article-title":"Molecular rescue of DYRK1A overexpression alterations in mice with fontup\u00ae dietary supplement: role of green tea catechins","volume":"21","author":"Gu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0755","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrn3192","article-title":"Mechanisms of CaMKII action in long-term potentiation","volume":"13","author":"Lisman","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0760","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neuron.2019.05.033","article-title":"CaM kinase: still inspiring at 40","volume":"103","author":"Bayer","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0765","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.neuron.2013.12.024","article-title":"CaMKII: claiming center stage in postsynaptic function and organization","volume":"81","author":"Hell","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113982","article-title":"Studying CaMKII: tools and standards","volume":"43","author":"Brown","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0775","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gene.2003.08.023","article-title":"Organization and evolution of multifunctional Ca2+\/CaM-dependent protein kinase genes","volume":"322","author":"Tombes","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0780","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0169-328X(99)00131-X","article-title":"Developmental expression of the CaM kinase II isoforms: ubiquitous \u03b3- and \u03b4-CaM kinase II are the early isoforms and most abundant in the developing nervous system","volume":"70","author":"Bayer","year":"1999","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0785","doi-asserted-by":"crossref","unstructured":"A.J. Silva, R. Paylor, J.M. Wehner, S. Tonegawa, Impaired Spatial Learning in \u03b1-Calcium-Calmodulin Kinase II Mutant Mice, Science (80-. ). 257 (1992) 206\u2013211. doi:https:\/\/doi.org\/10.1126\/science.1321493.","DOI":"10.1126\/science.1321493"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0790","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41586-023-06465-y","article-title":"LTP induction by structural rather than enzymatic functions of CaMKII","volume":"621","author":"Tullis","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0795","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.celrep.2014.01.005","article-title":"Autonomous CaMKII mediates both LTP and LTD using a mechanism for differential substrate site selection","volume":"6","author":"Coultrap","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0800","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41583-022-00624-2","article-title":"CaMKII: a central molecular organizer of synaptic plasticity, learning and memory","volume":"23","author":"Yasuda","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0805","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0006-8993(94)90979-2","article-title":"Calcium\/calmodulin-dependent protein kinase II immunostaining is preserved in Alzheimer\u2019s disease hippocampal neurons","volume":"657","author":"Simonian","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0810","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.brainres.2004.10.061","article-title":"The expression of calcium\/calmodulin-dependent protein kinase II-\u03b1 in the hippocampus of patients with Alzheimer\u2019s disease and its links with AD-related pathology","volume":"1031","author":"Wang","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0815","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1042\/bj3160655","article-title":"Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium\/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356","volume":"316","author":"Litersky","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0820","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-5793(96)00485-1","article-title":"Calcium\/calmodulin-dependent protein kinase II phosphorylates tau at Ser-262 but only partially inhibits its binding to microtubules","volume":"387","author":"Singh","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0825","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neulet.2003.09.037","article-title":"Phosphorylation of tau protein to sites found in Alzheimer\u2019s disease brain is catalyzed by Ca2+\/calmodulin-dependent protein kinase II as demonstrated tandem mass spectrometry","volume":"353","author":"Yoshimura","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0830","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1111\/j.1471-4159.2005.03307.x","article-title":"Phosphorylation of tau at serine 416 by ca 2+ \/calmodulin-dependent protein kinase II in neuronal soma in brain","volume":"94","author":"Yamamoto","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0835","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1152\/physrev.00014.2003","article-title":"Long-term potentiation and memory","volume":"84","author":"Lynch","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0840","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.neuro.23.1.649","article-title":"Synaptic plasticity and memory: An evaluation of the hypothesis","volume":"23","author":"Martin","year":"2000","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0845","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.neuron.2016.12.015","article-title":"A brief history of long-term potentiation","volume":"93","author":"Nicoll","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0850","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.celrep.2019.03.041","article-title":"Simultaneous live imaging of multiple endogenous proteins reveals a mechanism for Alzheimer\u2019s-related plasticity impairment","volume":"27","author":"Cook","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0855","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/35081080","article-title":"Interaction with the NMDA receptor locks CaMKII in an active conformation","volume":"411","author":"Bayer","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0860","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neuron.2005.08.034","article-title":"NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII","volume":"48","author":"Barria","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0865","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/emboj.2011.482","article-title":"CaMKII binding to GluN2B is critical during memory consolidation","volume":"31","author":"Halt","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104368","article-title":"A\u03b2-induced synaptic impairments require CaMKII activity that is stimulated by indirect signaling events","volume":"25","author":"Brown","year":"2022","journal-title":"IScience"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0875","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms15742","article-title":"The CaMKII holoenzyme structure in activation-competent conformations","volume":"8","author":"Myers","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0880","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh1069","article-title":"Imaging single CaMKII holoenzymes at work by high-speed atomic force microscopy","volume":"9","author":"Tsujioka","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0885","first-page":"1","article-title":"CaMKII inhibitors: from research tools to therapeutic agents","volume":"5 FEB","author":"Pellicena","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0890","doi-asserted-by":"crossref","first-page":"20675","DOI":"10.1074\/jbc.M109.088617","article-title":"Effective post-insult neuroprotection by a novel Ca2+\/ calmodulin-dependent protein kinase II (CaMKII) inhibitor","volume":"285","author":"Vest","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0895","doi-asserted-by":"crossref","unstructured":"H. Tokumitsu, T. Chijiwa, M. Hagiwara, A. Mizutani, M. Terasawa, H. Hidaka, KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+\/calmodulin-dependent protein kinase II., J. Biol. Chem. 265 (1990) 4315\u20134320. doi:https:\/\/doi.org\/10.1016\/S0021-9258(19)39565-1.","DOI":"10.1016\/S0021-9258(19)39565-1"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0900","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/0006-291X(91)92031-E","article-title":"The newly synthesized selective Ca2+calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells","volume":"181","author":"Sumi","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0905","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1096\/fj.201902135R","article-title":"Tau hyperphosphorylation induced by the anesthetic agent ketamine\/xylazine involved the calmodulin-dependent protein kinase II","volume":"34","author":"Hector","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0910","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1006\/bbrc.1995.2040","article-title":"A novel highly specific and potent inhibitor of calmodulin-dependent protein kinase II","volume":"212","author":"Ishida","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0915","doi-asserted-by":"crossref","first-page":"10890","DOI":"10.1073\/pnas.95.18.10890","article-title":"Characterization of a calmodulin kinase II inhibitor protein in brain","volume":"95","author":"Chang","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0920","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bja.2023.06.059","article-title":"Sevoflurane anaesthesia induces cognitive impairment in young mice through sequential tau phosphorylation","volume":"131","author":"Liang","year":"2023","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0925","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22081287","article-title":"Recent advances in the inhibition of p38 MAPK as a potential strategy for the treatment of Alzheimer\u2019s disease","volume":"22","author":"Lee","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0930","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.tips.2007.04.008","article-title":"Novel strategies for inhibition of the p38 MAPK pathway","volume":"28","author":"Zhang","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0935","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejmech.2018.10.030","article-title":"Tau tubulin kinase 1 (TTBK1), a new player in the fight against neurodegenerative diseases","volume":"161","author":"Nozal","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0940","doi-asserted-by":"crossref","first-page":"20052","DOI":"10.1074\/jbc.M001713200","article-title":"Crystal structure of a conformation-selective casein Kinase-1 inhibitor","volume":"275","author":"Mashhoon","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0945","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1016\/S0021-9258(19)34116-X","article-title":"Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma","volume":"265","author":"Chijiwa","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0950","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000017","article-title":"Role of a novel PH-kinase domain interface in PKB\/Akt regulation: structural mechanism for allosteric inhibition","volume":"7","author":"Calleja","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ijbiomac.2025.142141_bb0955","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/brain\/awn125","article-title":"STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer\u2019s \u03b2-amyloid deposits","volume":"131","author":"Cancino","year":"2008","journal-title":"Brain"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025026935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025026935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:41:59Z","timestamp":1782902519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025026935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":191,"alternative-id":["S0141813025026935"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142141","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Going beyond ATP binding site as a novel inhibitor design strategy for tau protein kinases in the treatment of Alzheimer's disease: A review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"142141"}}